Clinical trial
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
NCT03898973 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
- Lead sponsor
- Stanford University
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- April 11, 2019
- Completion date
- November 17, 2023
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza